Cargando…

Urine proteomics for prediction of disease progression in patients with IgA nephropathy

BACKGROUND: Risk of kidney function decline in immunoglobulin A (IgA) nephropathy (IgAN) is significant and may not be predicted by available clinical and histological tools. To serve this unmet need, we aimed at developing a urinary biomarker-based algorithm that predicts rapid disease progression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rudnicki, Michael, Siwy, Justyna, Wendt, Ralph, Lipphardt, Mark, Koziolek, Michael J, Maixnerova, Dita, Peters, Björn, Kerschbaum, Julia, Leierer, Johannes, Neprasova, Michaela, Banasik, Miroslaw, Sanz, Ana Belen, Perez-Gomez, Maria Vanessa, Ortiz, Alberto, Stegmayr, Bernd, Tesar, Vladimir, Mischak, Harald, Beige, Joachim, Reich, Heather N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719618/ https://www.ncbi.nlm.nih.gov/pubmed/33313853 http://dx.doi.org/10.1093/ndt/gfaa307

Ejemplares similares

Dynamics of urine proteomics biomarker and disease progression in patients with IgA nephropathy
por: Peters, Björn, et al.
Publicado: (2023)

Serum and Urine Biomarkers Related to Kidney Fibrosis Predict Kidney Outcome in Czech Patients with IgA Nephropathy
por: Neprasova, Michaela, et al.
Publicado: (2023)

Emerging Modes of Treatment of IgA Nephropathy
por: Maixnerova, Dita, et al.
Publicado: (2020)

The coincidence of IgA nephropathy and Fabry disease
por: Maixnerová, Dita, et al.
Publicado: (2013)

Expanding options of supportive care in IgA nephropathy
por: Maixnerova, Dita, et al.
Publicado: (2023)

Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression
por: Maixnerova, Dita, et al.
Publicado: (2019)

Correction: Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression
por: Maixnerova, Dita, et al.
Publicado: (2019)

Outcome of 313 Czech Patients With IgA Nephropathy After Renal Transplantation
por: Maixnerova, Dita, et al.
Publicado: (2021)

Toward Noninvasive Diagnosis of IgA Nephropathy: A Pilot Urinary Metabolomic and Proteomic Study
por: Neprasova, Michaela, et al.
Publicado: (2016)

Unique Biomarkers of Collagen Type III Remodeling Reflect Different Information Regarding Pathological Kidney Tissue Alterations in Patients with IgA Nephropathy
por: Sparding, Nadja, et al.
Publicado: (2023)

Proteomic characterization of obesity-related nephropathy
por: Wendt, Ralph, et al.
Publicado: (2020)

Recent Advances in Urinary Peptide and Proteomic Biomarkers in Chronic Kidney Disease: A Systematic Review
por: Catanese, Lorenzo, et al.
Publicado: (2023)

New Treatment Strategies for IgA Nephropathy: Targeting Plasma Cells as the Main Source of Pathogenic Antibodies
por: Maixnerova, Dita, et al.
Publicado: (2022)

Endotrophin, a collagen type VI-derived matrikine, reflects the degree of renal fibrosis in patients with IgA nephropathy and in patients with ANCA-associated vasculitis
por: Sparding, Nadja, et al.
Publicado: (2021)

A Novel Urinary Proteomics Classifier for Non-Invasive Evaluation of Interstitial Fibrosis and Tubular Atrophy in Chronic Kidney Disease
por: Catanese, Lorenzo, et al.
Publicado: (2021)

CD99 and polymeric immunoglobulin receptor peptides deregulation in critical COVID‐19: A potential link to molecular pathophysiology?
por: Siwy, Justyna, et al.
Publicado: (2021)

Plasma Exchange or Immunoadsorption in Demyelinating Diseases: A Meta-Analysis
por: Lipphardt, Mark, et al.
Publicado: (2020)

Molecular Mapping of Urinary Complement Peptides in Kidney Diseases
por: Wendt, Ralph, et al.
Publicado: (2021)

Urine Peptidome Analysis Identifies Common and Stage-Specific Markers in Early Versus Advanced CKD
por: Hobson, Sam, et al.
Publicado: (2023)

Collagen-Derived Peptides in CKD: A Link to Fibrosis
por: Mavrogeorgis, Emmanouil, et al.
Publicado: (2021)

Computational Drug Screening Identifies Compounds Targeting Renal Age-associated Molecular Profiles
por: Koppelstaetter, Christian, et al.
Publicado: (2019)

Coregulation Analysis of Mechanistic Biomarkers in Autosomal Dominant Polycystic Kidney Disease
por: Leierer, Johannes, et al.
Publicado: (2021)

Urinary peptides provide information about the risk of mortality across a spectrum of diseases and scenarios
por: Keller, Felix, et al.
Publicado: (2023)

Diagnostik und Therapie IgA Nephropathie – 2023
por: Schimpf, Judith, et al.
Publicado: (2023)

International Physicians Delphi Survey: Managing Patients With IgA Nephropathy
por: Floege, Jürgen, et al.
Publicado: (2022)

Challenges in IgA Nephropathy Management: An Era of Complement Inhibition
por: Tesař, Vladimir, et al.
Publicado: (2023)

Urinary peptidomic profiles to address age-related disabilities: a prospective population study
por: Martens, Dries S, et al.
Publicado: (2021)

Why Target the Gut to Treat IgA Nephropathy?
por: Barratt, Jonathan, et al.
Publicado: (2020)

Risk Factors Associated with Peritoneal-Dialysis-Related Peritonitis
por: Kerschbaum, Julia, et al.
Publicado: (2012)

Proteomic Candidate Biomarkers of Drug-Induced Nephrotoxicity in the Rat
por: Rouse, Rodney, et al.
Publicado: (2012)

Reproducibility Evaluation of Urinary Peptide Detection Using CE-MS
por: Mavrogeorgis, Emmanouil, et al.
Publicado: (2021)

Candidate Urine Peptide Biomarkers for IgA Nephropathy: Where Are We Now?
por: Marek-Bukowiec, Karolina, et al.
Publicado: (2018)

Urine peptidome in combination with transcriptomics analysis highlights MMP7, MMP14 and PCSK5 for further investigation in chronic kidney disease
por: Petra, Eleni, et al.
Publicado: (2022)

Proteomics as a Quality Control Tool of Pharmaceutical Probiotic Bacterial Lysate Products
por: Klein, Günter, et al.
Publicado: (2013)

Comparison of 24-h Urine Protein, Urine Albumin-to-Creatinine Ratio, and Protein-to-Creatinine Ratio in IgA Nephropathy
por: Yu, Guizhen, et al.
Publicado: (2022)

Osteopontin—A Potential Biomarker for IgA Nephropathy: Machine Learning Application
por: Moszczuk, Barbara, et al.
Publicado: (2022)

Eligibility for Baroreflex Activation Therapy and medication adherence in patients with apparently resistant hypertension
por: Schäfer, Ann‐Kathrin, et al.
Publicado: (2021)

Poor histological lesions in IgA nephropathy may be reflected in blood and urine peptide profiling
por: Graterol, Fredzzia, et al.
Publicado: (2013)

Urine Concentrating Capacity, Vasopressin and Copeptin in ADPKD and IgA Nephropathy Patients with Renal Impairment
por: Zittema, Debbie, et al.
Publicado: (2017)

Machine Learning-Based Urine Peptidome Analysis to Predict and Understand Mechanisms of Progression to Kidney Failure
por: Massy, Ziad A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pfdmd80po85u16oueoj757hsje